# ALBENDAZOLE
> **ANDA211117** · Abbreviated New Drug Application (Generic) · Sponsor: EDENBRIDGE PHARMS · Approved 2019-05-14
## Drug
- **FDA Application Number:** ANDA211117
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ALBENDAZOLE
- **Generic name:** ALBENDAZOLE
- **Active ingredients:** ALBENDAZOLE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EDENBRIDGE PHARMS
- **Manufacturer:** Edenbridge Pharmaceuticals LLC.
- **First approval:** 2019-05-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211117)
---
*MORVS · CC0 1.0*